Merck nears $10 billion deal for London-based lung therapy firm Verona, FT reports
Reutersarrow_outwardMerck Agrees to Buy Verona Pharma for About $10 Billion
Bloomberg.comarrow_outwardMerck nears $10bn deal for respiratory drugmaker Verona
Financial Timesarrow_outwardMerck to acquire Verona Pharma for $10 billion - Global Banking | Finance | Review
Global Banking | Finance | Reviewarrow_outwardMerck confirms $10B buyout of Verona Pharma (MRK:NYSE) - Seeking Alpha
Seeking Alphaarrow_outwardMerck to acquire Verona Pharma for $10 billion - MarketScreener
MarketScreenerarrow_outwardMerck to acquire Verona Pharma for $10 billion to add COPD treatment - StreetInsider
StreetInsiderarrow_outwardMerck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayreยฎ (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade - Business Wire
Business Wirearrow_outwardVerona Pharma (VRNA) Stocks Surge on Merck Acquisition Talks - GuruFocus
GuruFocusarrow_outwardIs MSD preparing a $10bn deal to buy Verona? - pharmaphorum
Pharmaphorumarrow_outwardMerck & Co. close to $10B deal for Verona: report - FirstWord Pharma
FirstWord Pharmaarrow_outwardVerona jumps 18% on report of $10B Merck takeover bid - breakingthenews.net
Breakingthenews.netarrow_outwardMerck to Acquire Verona for $10 Billion โ A Major Move into Respiratory Care, Shares of VRNA Surge 20% - Mitrade
Mitradearrow_outwardMerck nears $10B acquisition of Verona Pharma at $107 per share - report - Investing.com
Investing.comarrow_outwardMeck looks to soften impact of Keytruda cliff with $10bn tilt for Verona Pharma - Proactive Investors
Proactive Investorsarrow_outwardMerck nears $10B acquisition of Verona Pharma at $107 per share - report - Investing.com Canada
Investing.com Canadaarrow_outward(VRNA) On The My Stocks Page - news.stocktradersdaily.com
News.stocktradersdaily.comarrow_outwardPiper Sandler reiterates Overweight rating on Verona Pharma stock - Investing.com Australia
Investing.com Australiaarrow_outwardPiper Sandler reiterates Overweight rating on Verona Pharma stock By Investing.com - Investing.com South Africa
Investing.com South Africaarrow_outwardBest Momentum Stock To Buy For July 7th - Barchart.com
Barchart.comarrow_outwardPiper Sandler reiterates Overweight rating on Verona Pharma stock By Investing.com - Investing.com Nigeria
Investing.com Nigeriaarrow_outwardBest Momentum Stock to Buy for July 7th - Zacks Investment Research
Zacks Investment Researcharrow_outwardNew Strong Buy Stocks for July 7th - TradingView
TradingViewarrow_outwardWall Street Analysts Predict a 25.99% Upside in Verona Pharma (VRNA): Here's What You Should Know - MSN
MSNarrow_outwardZacks Industry Outlook Highlights Exelixis, Verona Pharma, Alkermes, Kiniska Pharmaceuticals and Immunocore - Yahoo Finance
Yahoo Financearrow_outwardVerona Pharma put volume heavy and directionally bearish - TipRanks
TipRanksarrow_outwardVerona Pharma's OHTUVAYRE: A COPD Breakthrough with Billion-Dollar Potential - AInvest
AInvestarrow_outwardRoth Capital Hikes Verona Pharmaโs (VRNA) Price Target to $116 On COPD Market Prospects - Yahoo
Yahooarrow_outwardJefferies Backs Verona Pharma plc (VRNA) After Strong Ohtuvayre Launch - Insider Monkey
Insider Monkeyarrow_outwardVerona Pharma Secures Speaking Slots at Two Major Healthcare Investor Conferences This June - Stock Titan
Stock Titanarrow_outwardNuance seeks China approval for Ohtuvayre following Phase III trial success - Clinical Trials Arena
Clinical Trials Arenaarrow_outwardIBD Stock Of The Day Verona Pharma Tests Buy Point After Earnings Breakout - Investor's Business Daily
Investor's Business Dailyarrow_outwardThis Just In: Analysts Are Boosting Their Verona Pharma plc (NASDAQ:VRNA) Outlook for This Year - simplywall.st
Simplywall.starrow_outwardVerona Pharma Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
GlobeNewswirearrow_outwardVerona Pharma Enhances Financial Flexibility With Capital Structure Changes - Nasdaq
Nasdaqarrow_outwardVerona touts 'exceptionally strong' launch of blockbuster hopeful COPD treatment Ohtuvayre - Fierce Pharma
Fierce Pharmaarrow_outwardOhtuvayre From Verona Pharma - Pharmacy Times
Pharmacy Timesarrow_outwardCaligan picks up a stake in Verona Pharma, seeing an opportunity to generate more value - CNBC
CNBCarrow_outward
Verona Pharma close
- 2025-07-09 18:50 event
- 38 sourceslanguage
- 200+ ads_click
- 3 days ago schedule